Skip to main content
Premium Trial:

Request an Annual Quote

NanoString COVID-19 Disease Research Products

NanoString Technologies has launched a set of new solutions for studying immune response in COVID-19 disease research, which include the Host Response Gene Expression Panel and COVID -19 Panel Plus spike-in, as well as new protein and RNA content available on the GeoMx Digital Spatial Profiler.

The COVID-19 GeoMx-formatted Antibody Panel, from Abcam, provides a customizable panel which will be run with the GeoMx Immune Profiling Core to enable spatial analysis of 96 proteins involved in the immune response to SARS-CoV-2 infection. It is currently available through NanoString's GeoMx technology access program. The Host Response assay includes 770 genes focused on host susceptibility, interferon signaling, innate and adaptive immunity as well as other key areas of biology to characterize host response to infection. The COVID-19 panel contains probes targeting all SARS-CoV-2 genes as well as the host ACE receptor that is bound by the virus. 

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.